iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Stock Price Up 1.5% – Time to Buy?

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)’s share price shot up 1.5% during trading on Tuesday . The stock traded as high as $31.45 and last traded at $31.17. 20,361 shares changed hands during trading, a decline of 48% from the average daily volume of 38,904 shares. The stock had previously closed at $30.70.

iShares Genomics Immunology and Healthcare ETF Stock Up 1.5%

The stock’s 50 day moving average price is $29.82 and its two-hundred day moving average price is $28.94. The firm has a market capitalization of $169.88 million, a price-to-earnings ratio of 14.76 and a beta of 0.96.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Portland Global Advisors LLC raised its stake in shares of iShares Genomics Immunology and Healthcare ETF by 0.7% during the 3rd quarter. Portland Global Advisors LLC now owns 103,007 shares of the company’s stock worth $2,432,000 after purchasing an additional 684 shares in the last quarter. Ameriprise Financial Inc. lifted its holdings in shares of iShares Genomics Immunology and Healthcare ETF by 8.4% during the 3rd quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock valued at $1,688,000 after buying an additional 5,540 shares during the last quarter. Finally, Triumph Capital Management acquired a new stake in shares of iShares Genomics Immunology and Healthcare ETF during the 3rd quarter valued at about $35,000.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.